July 3 (Reuters) - U.S. private equity firm Carlyle Group CG.O is preparing to offload up to a 10% stake in India's Piramal Pharma PIRM.NS through block trades, online news portal Moneycontrol reported on Thursday, citing sources.
The U.S.-based private equity firm could earn in the range of 26 billion rupees ($304.8 million) to 27 billion rupees from the sale, the report added.
($1 = 85.3090 Indian rupees)
(Reporting by Hritam Mukherjee in Bengaluru; Editing by Nivedita Bhattacharjee)
((Hritam.Mukherjee@thomsonreuters.com; X: @MukherjeeHritam;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。